Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Qi

Showing results (151-160 of 439) with videos related to

Pageof 44
Sort By:
The Journal of Antibiotics|April 1, 1984
A new naphthaquinone antibiotic from a new species of yeastT W Flegel, V Meevootisom, Y Thebtaranonth, et al.
The Journal of Biological Chemistry|January 27, 1998
Association of neurofilament proteins with neuronal Cdk5 activatorZ Qi, D Tang, X Zhu, et al.
Journal of Medical Economics|May 14, 2020
Estimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital's perspectiveHongbo Yang, Yanni Hao, Xinglei Chai, et al.
Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|March 1, 1982
Complete amino acid sequence of mung bean trypsin inhibitorY Zhang, S Luo, F Tan, et al.
FEBS Letters|March 12, 2004
Alpha-chimaerin exists in a functional complex with the Cdk5 kinase in brainRobert Z Qi, Yick-Pang Ching, Hsiang-Fu Kung, et al.
Advances in Therapy|August 30, 2022
Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018Yifei Liu, Martha Skup, Min Yang, et al.
The Journal of Biological Chemistry|November 25, 2003
Direct regulation of microtubule dynamics by protein kinase CK2Anthony C B Lim, Sock-Yeen Tiu, Qing Li, et al.
Panminerva Medica|June 3, 2010
Stem cells and hepatic cirrhosisZ Chen, L Z Qi, R Zeng, et al.
Journal of Medical Economics|December 7, 2020
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory <i>FLT3</i> <sup>mut+</sup> acute myeloid leukemia in a US health planBhavik J Pandya, Hongbo Yang, Cynthia Schmeichel, et al.
Clinical Therapeutics|August 12, 2021
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesCynthia Z Qi, Vamsi Bollu, Hongbo Yang, et al.
Pageof 44

Showing results (151-160 of 439) with videos related to

Sort By:
Pageof 44
The Journal of Antibiotics|April 1, 1984
A new naphthaquinone antibiotic from a new species of yeastT W Flegel, V Meevootisom, Y Thebtaranonth, et al.
The Journal of Biological Chemistry|January 27, 1998
Association of neurofilament proteins with neuronal Cdk5 activatorZ Qi, D Tang, X Zhu, et al.
Journal of Medical Economics|May 14, 2020
Estimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital's perspectiveHongbo Yang, Yanni Hao, Xinglei Chai, et al.
Scientia Sinica. Series B, Chemical, Biological, Agricultural, Medical & Earth Sciences|March 1, 1982
Complete amino acid sequence of mung bean trypsin inhibitorY Zhang, S Luo, F Tan, et al.
FEBS Letters|March 12, 2004
Alpha-chimaerin exists in a functional complex with the Cdk5 kinase in brainRobert Z Qi, Yick-Pang Ching, Hsiang-Fu Kung, et al.
Advances in Therapy|August 30, 2022
Correction to: Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018Yifei Liu, Martha Skup, Min Yang, et al.
The Journal of Biological Chemistry|November 25, 2003
Direct regulation of microtubule dynamics by protein kinase CK2Anthony C B Lim, Sock-Yeen Tiu, Qing Li, et al.
Panminerva Medica|June 3, 2010
Stem cells and hepatic cirrhosisZ Chen, L Z Qi, R Zeng, et al.
Journal of Medical Economics|December 7, 2020
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory <i>FLT3</i> <sup>mut+</sup> acute myeloid leukemia in a US health planBhavik J Pandya, Hongbo Yang, Cynthia Schmeichel, et al.
Clinical Therapeutics|August 12, 2021
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United StatesCynthia Z Qi, Vamsi Bollu, Hongbo Yang, et al.
Pageof 44